SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies informs about company updates

18 Jan 2019 Evaluate

Indoco Remedies has informed that, as informed in its quarterly MDA Synpsis, the Company was expecting re-inspection of Goa Plant I and Plant II by USFDA. Inspection of Goa PIant II (Sterile facility) was completed from 14 - 21 November, 2018 and Goa Plant I (Solid oral facility) inspection by USFDA has commenced since 17th January, 2019.

The above information is a part of company’s filings submitted to BSE.

Indoco Remedies Share Price

228.20 -23.05 (-9.17%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×